Sentinel node biopsy for melanoma

Is sentinel node biopsy in melanoma a test or a treatment?

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f677 (Published 6 February 2013)
Cite this as: BMJ 2013;346:f677

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anthony J Dixon, professor1
  1. 1Australasian College of Cutaneous Oncology, Belmont, VIC 3216, Australia
  1. anthony{at}acco.org.au

Ten years ago we hoped sentinel lymph node biopsy (SNB) “treatment” would prolong life for patients with melanoma. Then the first Multicenter Selective Lymphadenectomy Trial (MSLT-1) failed to show a five year survival advantage.1 Now we talk of the SNB “test” offering some patients a more accurate survival prediction.

We advise …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL